Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Depending on the exchange, the stock ticker may vary. For instance, on exchange Johnson & Johnson stocks are traded under the ticker JNJ.MU.
When is the next Johnson & Johnson earnings date?▼
Johnson & Johnson is going to release the next earnings report on April 14, 2026.
What were Johnson & Johnson earnings last quarter?▼
JNJ.MU earnings for the last quarter are 2.11 EUR per share, whereas the estimation was 2.11 EUR resulting in a -0.12% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Johnson & Johnson have?▼
As of April 12, 2026, the company has 141,700 employees.
In which sector is Johnson & Johnson located?▼
Johnson & Johnson operates in the Health & Wellness sector.
When did Johnson & Johnson complete a stock split?▼
Johnson & Johnson has not had any recent stock splits.
Where is Johnson & Johnson headquartered?▼
Johnson & Johnson is headquartered in New Brunswick, United States.